PG
TRV icon

Prostatis Group’s Travelers Companies TRV Stock Holding History

Prostatis Group’s Portfolio TRV Stock Details TRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Buy
2,060
+1,056
+105% +$320K 0.16% 95
2026
Q1 		$293K Sell
1,004
-50
-5% -$14.6K 0.08% 144
2025
Q4 		$306K Sell
1,054
-3,577
-77% -$1.01M 0.07% 134
2025
Q3 		$1.29M Buy
4,631
+606
+15% +$162K 0.32% 66
2025
Q2 		$1.08M Sell
4,025
-319
-7% -$84.1K 0.31% 67
2025
Q1 		$1.15M Sell
4,344
-934
-18% -$233K 0.36% 61
2024
Q4 		$1.27M Sell
5,278
-55
-1% -$13.7K 0.37% 63
2024
Q3 		$1.25M Buy
5,333
+503
+10% +$111K 0.41% 60
2024
Q2 		$999K Buy
4,830
+234
+5% +$50.3K 0.35% 66
2024
Q1 		$1.06M Buy
4,596
+676
+17% +$144K 0.4% 59
2023
Q4 		$747K Buy
3,920
+7
+0.2% +$1.21K 0.31% 73
2023
Q3 		$629K Sell
3,913
-320
-8% -$53.4K 0.31% 61
2023
Q2 		$735K Sell
4,233
-217
-5% -$38.3K 0.34% 62
2023
Q1 		$764K Sell
4,450
-26
-0.6% -$4.73K 0.4% 57
2022
Q4 		$839K Buy
+4,476
New +$805K 0.51% 46

Other funds holding TRV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Prostatis Group's TRV Position: Q2 2026 in Review

Prostatis Group increased its Travelers Companies (TRV) stake by 105% in Q2 2026, buying an estimated $320K and bringing the position to 2,060 shares worth $680K. The position accounts for 0.16% of the portfolio, ranked #95.

Prostatis Group first reported a position in TRV in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.29M in Q3 2025. 1,861 funds tracked by Wall St. Rank hold TRV as of Q2 2026.

  • Prostatis Group held 2,060 shares of Travelers Companies worth $680K as of Q2 2026.
  • Prostatis Group bought 1,056 Travelers Companies shares in Q2 2026, an estimated $320K.
  • Travelers Companies made up 0.16% of Prostatis Group's portfolio in Q2 2026, its #95 holding.
  • Prostatis Group first reported a position in Travelers Companies in Q4 2022 and has held it in 15 quarters since.
  • Prostatis Group's Travelers Companies position peaked at $1.29M in Q3 2025.
  • 1,861 funds tracked by Wall St. Rank held Travelers Companies as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.